Multiple Myeloma: Big Survival Gains from Novel Agents 'in the Real World' episode artwork

EPISODE · Jul 14, 2026 · 3 MIN

Multiple Myeloma: Big Survival Gains from Novel Agents 'in the Real World'

from Oncology Times - OncTimes Talk

Evangelos Terpos, speaking at the European Hematology Association 2010 Congress in Barcelona, discusses his group's encouraging findings based on 10 years of experience with thalidomide, lenalidomide, and bortezomib.

NOW PLAYING

Multiple Myeloma: Big Survival Gains from Novel Agents 'in the Real World'

0:00 3:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Times - OncTimes Talk?

This episode is 3 minutes long.

When was this Oncology Times - OncTimes Talk episode published?

This episode was published on July 14, 2026.

What is this episode about?

Evangelos Terpos, speaking at the European Hematology Association 2010 Congress in Barcelona, discusses his group's encouraging findings based on 10 years of experience with thalidomide, lenalidomide, and bortezomib.

Can I download this Oncology Times - OncTimes Talk episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!